Dean Investment Associates’s Eli Lilly LLY Stock Holding History

Dean Investment Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Hold	870	–	–	0.14%	163
2026 Q1	$800K	Hold	870	–	–	0.11%	169
2025 Q4	$935K	Hold	870	–	–	0.13%	177
2025 Q3	$664K	Hold	870	–	–	0.09%	190
2025 Q2	$678K	Hold	870	–	–	0.1%	189
2025 Q1	$719K	Hold	870	–	–	0.11%	198
2024 Q4	$672K	Hold	870	–	–	0.1%	200
2024 Q3	$771K	Hold	870	–	–	0.1%	197
2024 Q2	$788K	Hold	870	–	–	0.11%	195
2024 Q1	$677K	Hold	870	–	–	0.09%	190
2023 Q4	$507K	Hold	870	–	–	0.07%	192
2023 Q3	$467K	Hold	870	–	–	0.08%	191
2023 Q2	$408K	Hold	870	–	–	0.07%	201
2023 Q1	$299K	Hold	870	–	–	0.05%	204
2022 Q4	$318K	Hold	870	–	–	0.05%	217
2022 Q3	$281K	Hold	870	–	–	0.06%	216
2022 Q2	$282K	Hold	870	–	–	0.05%	225
2022 Q1	$249K	Hold	870	–	–	0.04%	226
2021 Q4	$240K	Hold	870	–	–	0.04%	230
2021 Q3	$201K	Buy	+870	New	+$215K	0.04%	232

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dean Investment Associates's LLY Position: Q2 2026 in Review

Dean Investment Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 870 shares worth $1.04M. The position accounts for 0.14% of the portfolio, ranked #163.

Dean Investment Associates first reported a position in LLY in Q3 2021 and has held it in 20 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Dean Investment Associates held 870 shares of Eli Lilly worth $1.04M as of Q2 2026.
Dean Investment Associates left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.14% of Dean Investment Associates's portfolio in Q2 2026, its #163 holding.
Dean Investment Associates first reported a position in Eli Lilly in Q3 2021 and has held it in 20 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.